These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34936714)

  • 21. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Xu Z; Mei F; Liu H; Sun C; Zheng Z
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.
    Papadakis KA; Prehn J; Moreno ST; Cheng L; Kouroumalis EA; Deem R; Breaverman T; Ponath PD; Andrew DP; Green PH; Hodge MR; Binder SW; Targan SR
    Gastroenterology; 2001 Aug; 121(2):246-54. PubMed ID: 11487533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR9 and CCL25: A review of their roles in tumor promotion.
    Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
    J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
    Szlenk CT; Gc JB; Natesan S
    Mol Pharmacol; 2019 Nov; 96(5):527-541. PubMed ID: 30967440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
    Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
    Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA; Chen J; Cunningham KA; Zhou J
    J Med Chem; 2019 Jan; 62(1):88-127. PubMed ID: 30106578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR9 in cancer: oncogenic role and therapeutic targeting.
    Tu Z; Xiao R; Xiong J; Tembo KM; Deng X; Xiong M; Liu P; Wang M; Zhang Q
    J Hematol Oncol; 2016 Feb; 9():10. PubMed ID: 26879872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Heteromeric Complex Formed by Dopamine Receptor D
    Osorio-Barrios F; Navarro G; Campos J; Ugalde V; Prado C; Raïch I; Contreras F; López E; Espinoza A; Lladser A; Franco R; Pacheco R
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):489-506. PubMed ID: 33864900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse relationship between dendritic cell CCR9 expression and maturation state.
    Drakes ML; Stiff PJ; Blanchard TG
    Immunology; 2009 Aug; 127(4):466-76. PubMed ID: 19604301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the CCR3 and CCR9 genes in miiuy croaker and different selection pressures imposed on different domains between mammals and teleosts.
    Zhu Z; Wang R; Ren L; Xu T
    Dev Comp Immunol; 2013 Dec; 41(4):631-43. PubMed ID: 23817141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating structural and mutagenesis data to elucidate GPCR ligand binding.
    Munk C; Harpsøe K; Hauser AS; Isberg V; Gloriam DE
    Curr Opin Pharmacol; 2016 Oct; 30():51-58. PubMed ID: 27475047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
    Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
    Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.